Show simple item record

dc.contributor.authorBlay, Sergio L. [UNIFESP]
dc.contributor.authorFillenbaum, Gerda G.
dc.contributor.authorPitta, Jose C. [UNIFESP]
dc.contributor.authorPeluso, Erica T.
dc.date.accessioned2016-01-24T14:37:16Z
dc.date.available2016-01-24T14:37:16Z
dc.date.issued2014-05-01
dc.identifierhttp://dx.doi.org/10.1097/YIC.0000000000000008
dc.identifier.citationInternational Clinical Psychopharmacology. Philadelphia: Lippincott Williams & Wilkins, v. 29, n. 3, p. 157-165, 2014.
dc.identifier.issn0268-1315
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/37747
dc.description.abstractThe objective of this study was to examine the prevalence and characteristics of adult psychotropic medication use in São Paulo, Brazil. Information on lifetime and 12-month psychotropic medication use, and psychiatric status was obtained from a representative sample of 2000 adults aged 18-65 years in São Paulo, Brazil. Lifetime and 12-month use of psychotropic medications was 16.8 and 7.1%, respectively. of the 22.8% of patients with current psychiatric problems, 29.5% reported lifetime use and 15.8% (5.6% of the sample) reported 12-month use (anxiolytics: 2.7%, antidepressants: 1.8%, alternative medicines: 0.9%, antipsychotics: 0.4%, mood stabilizers: 0.4%, hypnotics: 0.3%; multiple class use occurred). the most frequent prescribers were psychiatrists and general practitioners. Determinants of use included identification as a psychiatric case (four-fold increased odds), being female (three-fold increase), age (4-5% per additional year), and lower odds if married. Education, employment status, and birth in São Paulo were not associated with use. Income did not affect anxiolytic use, but antidepressant and alternative medicine use was associated with higher income. These results show that psychotropic drug use was comparatively low. Only 15.8% of patients with psychiatric problems reported recent psychotropic use. Comparable with other studies, use was greater among women and increased with age.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipBolsista de Produtividade em Pesquisa
dc.description.sponsorshipNational Institute on Aging
dc.format.extent157-165
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofInternational Clinical Psychopharmacology
dc.rightsAcesso restrito
dc.subjectmiddle-income countryen
dc.subjectpsychiatric problemsen
dc.subjectantidepressantsen
dc.subjectpharmacoepidemiologyen
dc.subjectdepressionen
dc.subjectanxiolyticsen
dc.subjectBrazilen
dc.subjectpsychotropic drugsen
dc.titleFactors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazilen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Bandeirante São Paulo
dc.contributor.institutionDuke Univ
dc.description.affiliationUniversidade Federal de São Paulo, Paulista Sch Med UNIFESP, Dept Psychiat, São Paulo, Brazil
dc.description.affiliationUniv Bandeirante São Paulo, São Paulo, Brazil
dc.description.affiliationDuke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Paulista Sch Med UNIFESP, Dept Psychiat, São Paulo, Brazil
dc.description.sponsorshipIDFAPESP: 01/03423-0
dc.description.sponsorshipIDBolsista de Produtividade em Pesquisa: 306156/2011-3
dc.description.sponsorshipIDNational Institute on Aging: 1P30 AG028716
dc.identifier.doi10.1097/YIC.0000000000000008
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000334103600004


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record